Fig. 1From: Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular eventsPostprandial triglyceride concentration curve during MMTT at baseline and 6 months in all 16 patients. Values are expressed as median (Q1-Q3). DMR: Duodenal Mucosal resurfacing, MMTT: mixed meal tolerance testBack to article page